Vol. 21 No. 4 (2015)

Published: 2016-01-11

Commentary

US Supreme Courtâ€™s Decision on the Patent Ineligibility of Human Genes - BRCA1/BRCA2 as Products of Nature

Ananda Mohan Chakrabarty
- PDF
Flavonoids â€“ World Healthiest Gift for the Benefit of Human Health

Abhishek Kumar Yadav
- PDF
Undermining Patient Values: The ASCO Value in Cancer Care Task Force Framework

Peter J. Pitts, Robert Goldberg
- PDF

Article

Investment in Life Sciences in Scotland: Challenges and Opportunities

Andrew Henderson
- PDF
Crowdfunding: A New Untapped Opportunity for Biotechnology Start-ups?

Sholeh Azar, Timothy Ken Mackey
- PDF
EmergingCo: A Virtual â€œSouth-Southâ€ Biotech Model

ajay gautam
- PDF

Legal and Regulatory Updates

The FDA's Quality Revolution

Peter J. Pitts
- PDF
Biosimilars in Brazil: developments in 2015 and business perspectives

Denise Golgher, Roberto Rodrigues, Rodrigo Couto Massafera
- PDF